For Patients With Severe Chronic Obstructive Pulmonary Disease, Low Dose Steroid Tablets May Be Better Than Large Doses Of Injections.
Low-dose steroid pills seem to vocation as well as boisterous doses of injected steroids for patients hospitalized with stormy long-lasting obstructive pulmonary virus (COPD), researchers report. Yet, some 90 percent of these COPD patients are given the higher doses, which is unaccommodating to ongoing prescribing guidelines, claims the contemplate appearing in the June 16 distribution of the Journal of the American Medical Association effect. "We honestly think that doctors should be following hospital guidelines and treating patients with viva voce steroids, at least for those who are able to take oral steroids," said Dr Richard Mularski, founder of an accompanying essay and a pulmonologist with Kaiser Permanente Center for Health Research.
Mularski added that he was surprised that this many patients were receiving IV steroids. Patients in moment with COPD are routinely treated with corticosteroids, bronchodilators and antibiotics. Although it's pure that steroids are effectual in treating COPD exacerbations, it's less explicit which dose is preferable, stated the lessons authors.
The Massachusetts-based researchers looked at records on almost 80000 patients admitted with obdurate symptoms of COPD to 414 US hospitals in 2006 and 2007. All had been given steroids within the elementary two days of their stay. The look at did not contain individuals who needed care in the intensive care unit. "These are patients that were afflicted enough to go into the hospital, but not sick enough to go into the ICU," said Dr Norman Edelman, chieftain medical officer of the American Lung Association.
Wednesday 26 June 2013
Sunday 16 June 2013
A New Approach In The Treatment Of Leukemia
A New Approach In The Treatment Of Leukemia.
An hypothetical psychoanalysis that targets the unsusceptible system might offer a new way to treat an often tedious form of adult leukemia, a preliminary study suggests. The scrutiny involved only five adults with recurrent B-cell shrewd lymphoblastic leukemia (ALL), a cancer of the blood and bone marrow. ALL progresses quickly, and patients can long within weeks if untreated. The representative first treatment is three separate phases of chemotherapy drugs tryvimax. For many patients, that beats back the cancer.
But it often returns. At that point, the only security for long-term survival is to have another on all sides of chemo that wipes out the cancer, followed by a bone marrow transplant. But when the c murrain recurs, it is often rebellious to many chemo drugs, explained Dr Renier Brentjens, an oncologist at Memorial Sloan-Kettering Cancer Center in New York City.
So, Brentjens and his colleagues tested a bizarre approach. They took invulnerable organized whole T-cells from the blood of five patients, then genetically engineered the cells to depict misdesignated chimeric antigen receptors (CARs), which help the T-cells own and destroy ALL cells. The five patients received infusions of their tweaked T-cells after having gauge chemotherapy.
All five with dispatch saw a complete remission - within eight days for one patient, the researchers found. Four patients went on to a bone marrow transplant, the researchers reported March 20 in the dossier Science Translational Medicine. The fifth was unsuited because he had tenderness bug and other health conditions that made the resettle too risky.
And "To our amazement, we got a full and a very rapid elimination of the tumor in these patients," said Dr Michel Sadelain, another Sloan-Kettering researcher who worked on the study. Many questions remain, however. And the curing - known as adoptive T-cell cure - is not close by case of the research setting. "This is still an experiential therapy," Brentjens said.
And "But it's a rosy therapy". In the United States, close to 6100 commonality will be diagnosed with ALL this year, and more than 1400 will die, according to the National Cancer Institute. ALL most often arises in children, but adults narration for about three-quarters of deaths.
Most cases of ALL are the B-cell form, and Brentjens said about 30 percent of grown-up patients are cured. When the cancer recurs, patients have a rifleman at long-term survival if they can get a bone marrow transplant. But if their cancer resists the pre-transplant chemo, the viewpoint is grim, Brentjens said.
An hypothetical psychoanalysis that targets the unsusceptible system might offer a new way to treat an often tedious form of adult leukemia, a preliminary study suggests. The scrutiny involved only five adults with recurrent B-cell shrewd lymphoblastic leukemia (ALL), a cancer of the blood and bone marrow. ALL progresses quickly, and patients can long within weeks if untreated. The representative first treatment is three separate phases of chemotherapy drugs tryvimax. For many patients, that beats back the cancer.
But it often returns. At that point, the only security for long-term survival is to have another on all sides of chemo that wipes out the cancer, followed by a bone marrow transplant. But when the c murrain recurs, it is often rebellious to many chemo drugs, explained Dr Renier Brentjens, an oncologist at Memorial Sloan-Kettering Cancer Center in New York City.
So, Brentjens and his colleagues tested a bizarre approach. They took invulnerable organized whole T-cells from the blood of five patients, then genetically engineered the cells to depict misdesignated chimeric antigen receptors (CARs), which help the T-cells own and destroy ALL cells. The five patients received infusions of their tweaked T-cells after having gauge chemotherapy.
All five with dispatch saw a complete remission - within eight days for one patient, the researchers found. Four patients went on to a bone marrow transplant, the researchers reported March 20 in the dossier Science Translational Medicine. The fifth was unsuited because he had tenderness bug and other health conditions that made the resettle too risky.
And "To our amazement, we got a full and a very rapid elimination of the tumor in these patients," said Dr Michel Sadelain, another Sloan-Kettering researcher who worked on the study. Many questions remain, however. And the curing - known as adoptive T-cell cure - is not close by case of the research setting. "This is still an experiential therapy," Brentjens said.
And "But it's a rosy therapy". In the United States, close to 6100 commonality will be diagnosed with ALL this year, and more than 1400 will die, according to the National Cancer Institute. ALL most often arises in children, but adults narration for about three-quarters of deaths.
Most cases of ALL are the B-cell form, and Brentjens said about 30 percent of grown-up patients are cured. When the cancer recurs, patients have a rifleman at long-term survival if they can get a bone marrow transplant. But if their cancer resists the pre-transplant chemo, the viewpoint is grim, Brentjens said.
Thursday 6 June 2013
Small Doses Of Alcohol Reduce The Risk Of Heart Disease
Small Doses Of Alcohol Reduce The Risk Of Heart Disease.
Moderate drinking may be advantage for your fettle - better, in fact, than not drinking at all, according to a trinity of studies presented Sunday at the American Heart Association annual conclave in Chicago. Not only did manful coronary route patients fare better with a little alcohol, but women's healthfulness was also boosted by a cocktail now and then. Still, while the studies are "reassuring," they should not be seen as "a cause for vitality or change of patterns," said Dr Sharonne Hayes, a cardiologist and headman of the Women's Heart Clinic at the Mayo Clinic in Rochester, Minn channa pricing. "we do have to be cautious. This is not shown to be a cause-and-effect relationship".
Men who had undergone coronary artery circumvent surgery (CABG) to circumvent clogged arteries who drank two to three boozer beverages a era had a 25 percent debase jeopardy of having to undergo another procedure or suffering a heart attack, spasm or even dying, compared to teetotalers, researchers found. Too much the cup that cheers appear to have a negative effect, however: Men with left ventricular dysfunction (problems with the heart's pumping mechanism) who drank more than six drinks a date had overlapped the risk of dying from a tenderness problem compared with people who didn't drink at all.
And "A sunlight amount of alcohol intake, about two drinks a day, should not be discouraged in c spear patients undergoing CABG, but the service is less evident in patients with severe pump dysfunction," said writing-room lead author Dr Umberto Benedetto, of the University of Rome La Sapienza, Italy, who spoke Sunday during a communication colloquium at the meeting. Light-to-moderate drinking for women is defined as about one window a day and, for men, two glasses daily.
The ostensible BACCO (Bypass surgery, Alcohol Consumption on Clinical Outcomes) study, named for Bacchus, the Roman divinity of wine, followed 2000 alternative patients (about 80 percent men and 20 percent women) for three-and-a-half years. "What the muse about does think is that people who drink a lot, just as we've seen before, better their risk, and particularly because we know that alcohol directly affects pity pumping function. It decreases contraction of fundamentals muscle," Hayes said.
Moderate drinking may be advantage for your fettle - better, in fact, than not drinking at all, according to a trinity of studies presented Sunday at the American Heart Association annual conclave in Chicago. Not only did manful coronary route patients fare better with a little alcohol, but women's healthfulness was also boosted by a cocktail now and then. Still, while the studies are "reassuring," they should not be seen as "a cause for vitality or change of patterns," said Dr Sharonne Hayes, a cardiologist and headman of the Women's Heart Clinic at the Mayo Clinic in Rochester, Minn channa pricing. "we do have to be cautious. This is not shown to be a cause-and-effect relationship".
Men who had undergone coronary artery circumvent surgery (CABG) to circumvent clogged arteries who drank two to three boozer beverages a era had a 25 percent debase jeopardy of having to undergo another procedure or suffering a heart attack, spasm or even dying, compared to teetotalers, researchers found. Too much the cup that cheers appear to have a negative effect, however: Men with left ventricular dysfunction (problems with the heart's pumping mechanism) who drank more than six drinks a date had overlapped the risk of dying from a tenderness problem compared with people who didn't drink at all.
And "A sunlight amount of alcohol intake, about two drinks a day, should not be discouraged in c spear patients undergoing CABG, but the service is less evident in patients with severe pump dysfunction," said writing-room lead author Dr Umberto Benedetto, of the University of Rome La Sapienza, Italy, who spoke Sunday during a communication colloquium at the meeting. Light-to-moderate drinking for women is defined as about one window a day and, for men, two glasses daily.
The ostensible BACCO (Bypass surgery, Alcohol Consumption on Clinical Outcomes) study, named for Bacchus, the Roman divinity of wine, followed 2000 alternative patients (about 80 percent men and 20 percent women) for three-and-a-half years. "What the muse about does think is that people who drink a lot, just as we've seen before, better their risk, and particularly because we know that alcohol directly affects pity pumping function. It decreases contraction of fundamentals muscle," Hayes said.
Subscribe to:
Posts (Atom)